FLOATING DRUG DELIVERY SYSTEM: A REVIEW

Archana Tomar; Arpita Singh; Amresh Gupta; Satyawan Singh

doi:10.46956/ijihd.vi.112

Archana Tomar GOEL Institute of Pharmacy & Sciences, Faizabad Road, Beside Indira Canal, Lucknow, 226028, India
Arpita Singh GOEL Institute of Pharmacy & Sciences, Faizabad Road, Beside Indira Canal, Lucknow, 226028, India
Amresh Gupta GOEL Institute of Pharmacy & Sciences, Faizabad Road, Beside Indira Canal, Lucknow, 226028, India
Satyawan Singh GOEL Institute of Pharmacy & Sciences, Faizabad Road, Beside Indira Canal, Lucknow, 226028, India

DOI https://doi.org/10.46956/ijihd.vi.112

Abstract

The main motto of working on that article on floating drug delivery systems (FDDS) is to make a compiled report on the recent studies and research with special consideration on the principle mechanism of flotation to achieve gastric retention. The scientiﬁc and technological advancements were made in the last few years in the research and development of rate-controlled oral drug delivery systems by overcoming physiological difficulties, like short gastric residence times (GRT) and unpredictable gastric emptying times (GET). This review also epitomized the in-vitro procedure, in-vivo to assess the pursuance and implementation of floating systems, and applications of these systems. These methods are useful to various queries experienced during the development of a pharmaceutical dosage form.

Keywords: Floating Drug Delivery System, internal organ duration, Rate management, internal organ removal Time

Downloads

Download data is not yet available.

References

1. Yasunori Sato, Yoshiaki Kawashima, Hirofumi takeuchi, hiromitsu yamamoto. Euro J Pharm and Biopharm 2004; 57: 235– 243.
2. Desai, S.; Bolton, S. A floating controlled release drug delivery system: in vitro-in vivo evaluation. Pharm.Res., 1993;.10:1321-1325,.
3. Reddy L.H, Murthy R.H, Floating dosage systems in drug delivery, Crit.Rev. Ther. Drug Carr. Syst. 2002, 19(6):553-585.
4. Garg S. and Sharma S. Gastroretentive Drug Delivery System, Business Briefing: Pharmatech. 2003, 160-166.
5. Roy H.M, U.S. Patent no. 4055178, 1977.
6. Thanoo B.C, Sunny M.C. and Jayakrishnan A., Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid, J. Pharm. Pharmacol. 1993,45,21-24.
7. Sato Y., Kawashima Y., Takeuchi H. and Yamamoto H., In vivo evaluation of riboflavin containing micro balloons for floating controlled drug delivery .system in healthy human volunteers, J. Cont. Rel. 2003, 93, 39- 47.
8. El-Kamel A.H., Sokar M.S, Algamal S.S, Naggar V.F. Preparation and evaluation of ketoprofen floating oral drug delivery system. Int. J. Pharm. 2001;220:13-21.
9. Kawashima Y., Niwa T., Takeuchi H., Hino T., ItoY. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resins containing tranilast and their drug release characteristics (in vivo). J. Cont. Rel. 1991; 16:279-290.
10. Gu T.H. et al. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets.
Chung Kao Yao Li Hsuesh Pao. 1992;13:527-531
11. Ichikawa M., Watanabe S., Miyake Y. A new multiple units oral floating dosage systems. II: In vivo evaluation of floating and sustained release characteristics with para-aminobenzoic acid and isosorbide dinitrate as model drugs. J. Pharm. Sci. 1991;80:1153- 1156.
12. Rouge N., Cole E.T., Doelker E., Buri P. Buoyancy and drug release patterns of floating mini tablets containing piretanide and atenolol as model drugs. Pharm. Dev. Technol.
1998; 3:73-84.
13. Cheuh H.R., Zia H., Rhodes C.T. Optimization of Sotalol floating and bioadhesive extended-release tablet formulation. Drug Dev. Ind. Pharm.1995 ; 21 :1725-1747.
14. Gustafson J.H., Weissman L., Weinfeld R.T. et al. Clinical bioavailability evaluation of a controlled release formulation of diazepam. J. Pharmacokinet. Biopharm. 1981;9:679-691.
15. Patel GM. Floating drug delivery system: An
innovative approach to prolong gastric retention.
www.pharmainfo.net, 2007.
16. Desai S. A Novel Floating Controlled Release Drug Delivery System Based on a Dried Gel Matrix Network *master’s thesis+, Jamaica, NY: St John’s University;1984.
17. Chawla G, Gupta P, Koradia V, Bansal AK.
Gastroretention: A Means to address regional
variability in intestinal drug absorption. Pharm Tech 2003; 27: 250‐268.
18. Muller‐Lissner SA, Blum AL. The effect of specific gravity and eating on gastric emptying of slow‐release capsules. New Engl JMed1981; 304: 1365‐1366.
19. Singh BN, Kim KH. Floating drug delivery system: An approach to the controlled drug delivery via gastric retention. J Control Release 2000; 63: 235‐259.
20. Shah SH, Patel JK, Patel NV. Stomach specific floating drug delivery system: A review. Int J Pharm Res 2009; 1(3): 623‐633.
21. Gupta P, Virmani K, Garg S. Hydrogels: From controlled release to pH-responsive drug delivery.Drug Discovery Today 2002; 7(10): 569‐579.
22. Kedzierewicz F, Thaivenot P, Hoffman M, Maincent P.Evaluation for peroral silicon dosage forms in humans by gamma‐scintigraphy. J Control Release 1999; 58: 195‐205.
23. Patel R. Recent development in floating drug delivery system for gastric retention of drugs: an overview. 2007;http://www.swatijaininst.com/etechno/feb 2007 /roma.rtf.
24. Mayavanshi AV, Gajjar SS. Floating drug delivery systems to increase gastric retention of drugs: A Review. J Pharm Tech 2008; 1(14): 345‐348.
25. Whitehead L, Collet JH, Fell JT, Sharma HL, Smith AM. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J ControlRelease 1998; 55: 3‐12.
26. Iannuccelli V, Coppi G, Cameroin R. Air compartment
multiple unit system for prolonged gastric residence.
II. In vivo evaluation. Int J Pharm 1998; 174: 55‐62.